Neurologic - Intra-Cellular Therapies, Inc

Neurologic

Status:

Open/Enrolling

ClinicalTrials.gov:

A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Lenrispodun as Adjunctive Therapy in the Treatment of Patients with Motor Fluctuations due to Parkinson’s Disease

Drug

Lenrispodun

Phase

Phase II

Condition

Parkinson's Disease

Keywords